Different Immunochemotherapies in Small B-cell Non-Hodgkin Lymphoma (iNHL)
NCT06170216 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 220
Last updated 2024-02-23
Summary
Describe the application status of different immunochemotherapies in small B-cell non-Hodgkin lymphoma (iNHL), observe the therapeutic efficacy and safety of the treatment modalities.
Conditions
- Lymphoma, Non-Hodgkin
Interventions
- DRUG
-
immunochemotherapies
Observing different immunochemotherapies in small B-cell non-Hodgkin lymphoma (iNHL), which are chosen by investigators, such as RCHOP, BR, RCVP, etc.
Sponsors & Collaborators
-
Fudan University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-10
- Primary Completion
- 2023-12-19
- Completion
- 2026-01-10
Countries
- China
Study Locations
More Related Trials
-
A Trial to Compare Ibrutinib Versus Lenalidomide in Combination With MRE-chemotherapy for Adult Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL)
NCT04129710 ·Status: RECRUITING ·Phase: PHASE2
-
A Trial of SHR-A1912 Combined With Other Therapies in B-cell Non-Hodgkin 's Lymphoma
NCT06104553 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
NCT04028440 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
CMOP Regimen and Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma
NCT05896813 ·Status: UNKNOWN ·Phase: NA
-
A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL)
NCT06170489 ·Status: RECRUITING ·Phase: PHASE3
-
A Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-NHL
NCT03299738 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of a Sintilimab Plus ICE Regimen Versus ICE Regimen in Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed First-line Standard Chemotherapy
NCT04044222 ·Status: UNKNOWN ·Phase: PHASE3
-
Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients
NCT04696705 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)
NCT04245839 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Radiation Free Chemotherapy for Early Hodgkin Lymphoma
NCT04866654 ·Status: RECRUITING ·Phase: PHASE2
-
Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma
NCT01679860 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Safety, Tolerability and Pharmacokinetics of HZ-A-018 in Patients With B Cell Lymphoma
NCT04173455 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of Efficacy and Safety of Glofitamab in Combination With Salvage Therapy in a Real-world Setting in Chinese Adult Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.
NCT06497452 ·Status: RECRUITING
-
A Study of RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
NCT05444322 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Study of Zimberelimab(GLS-010) Combined With AVD for Newly Diagnosed Early-stage Hodgkin's Lymphoma
NCT05900765 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma
NCT04977167 ·Status: RECRUITING ·Phase: PHASE1
-
Retrospective Analysis of Rituximab-containing Immunochemotherapy for Burkitt's or Burkitt-like Lymphoma in Adults
NCT01809600 ·Status: COMPLETED
-
Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors
NCT02929615 ·Status: UNKNOWN ·Phase: PHASE4
-
Incidence of Hepatitis B Virus (HBV) Reactivation in HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOP
NCT01210287 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma
NCT02253992 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Lenalidomide Combined With R-CHOP(R2-CHOP) in Newly Diagnosed Double-expressor Diffuse Large B-Cell Lymphoma Patients
NCT04164368 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.
NCT06970496 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's Lymphoma
NCT00003204 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study of Injectable IMM0306 in Combination With Lenalidomide
NCT05771883 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Rituximab Combined With Chidamide and Lenalidomide for r/r AITL
NCT04319601 ·Status: UNKNOWN ·Phase: NA